PlexusDx prescribers evaluate your full medical history and typically recommend optimizing GLP-1 therapy alone first, since most patients achieve substantial weight loss without additional agents
This consideration is especially pertinent for women experiencing hormonal fluctuations during perimenopause or menopause, as the introduction of a medication that affects appetite and weight can intensify existing mental health challenges
Decreases in maternal body weight, food consumption, and motor activity were observed concurrent with the fetal findings, which confounds the interpretation of relevance of these malformations to the human risk assessment
If youre considering stopping tirzepatide, we may recommend a gradual reduction in the medication, paired with increased support for nutrition, physical activity, and behavioral strategies to help you maintain your results
Manufacturing defects or packaging failures are rare but possible causes of abnormal coloration
GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications